Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
MGI Tech Partners with Genoks to Enhance Clinical Testing Services in Türkiye
CompanyDeals

MGI Tech Partners with Genoks to Enhance Clinical Testing Services in Türkiye

May 15, 2025
Jiangsu Hengrui Pharmaceuticals Launches Hong Kong IPO of H-Shares
CompanyDeals

Jiangsu Hengrui Pharmaceuticals Launches Hong Kong IPO of H-Shares

May 15, 2025
CSPC Pharma Licenses Irinotecan Liposome Injection to Cipla for US Market
CompanyDeals

CSPC Pharma Licenses Irinotecan Liposome Injection to Cipla for US Market

May 15, 2025
WuHan Hamilton Biotech's HUC-MSCs Product Approved for Clinical Trials in Premature Ovarian Failure
CompanyDrug

WuHan Hamilton Biotech’s HUC-MSCs Product Approved for Clinical Trials in Premature Ovarian Failure

May 15, 2025
AbbVie Pays $335 Million Upfront to ADARx for Next-Gen siRNA Therapeutics
Others

AbbVie Pays $335 Million Upfront to ADARx for Next-Gen siRNA Therapeutics

May 15, 2025
Roche's VENTANA MET (SP44) RxDx Assay Gains FDA Approval for NSQ-NSCLC Patients
CompanyMedical Device

Roche’s VENTANA MET (SP44) RxDx Assay Gains FDA Approval for NSQ-NSCLC Patients

May 15, 2025
Novo Nordisk and Septerna Ink $2.2 Billion Deal for GPCR Drug Discovery
CompanyDeals

Novo Nordisk and Septerna Ink $2.2 Billion Deal for GPCR Drug Discovery

May 15, 2025
Sanofi Announces $20 Billion Investment in US R&D and Manufacturing by 2030
Company

Sanofi Announces $20 Billion Investment in US R&D and Manufacturing by 2030

May 15, 2025
GSK Signs Deal to Acquire Boston Pharmaceuticals' Efimosfermin Alpha
CompanyDeals

GSK Signs Deal to Acquire Boston Pharmaceuticals’ Efimosfermin Alpha

May 14, 2025
Acchrom Technologies Secures Pre-Series B Funding to Expand Chromatography Solutions
CompanyDeals

Acchrom Technologies Secures Pre-Series B Funding to Expand Chromatography Solutions

May 14, 2025
Ningbo Jansen Files STAR IPO for MRI Technology Expansion
CompanyDeals

Ningbo Jansen Files STAR IPO for MRI Technology Expansion

May 14, 2025
China's Q1 2025 Pharmaceutical Exports Rise 4.39% Despite Import Decline
CompanyDrug

China’s Q1 2025 Pharmaceutical Exports Rise 4.39% Despite Import Decline

May 14, 2025
1 2 … 164 165 166 167 168 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up